中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
3期
111-112,113
,共3页
急性肾衰竭%血液净化%疗效
急性腎衰竭%血液淨化%療效
급성신쇠갈%혈액정화%료효
Acute renal failure%Blood purification%Curative effect
目的：探讨持续血液净化（BP）在肾内科治疗中的疗效。方法：选择116例ARF患者，按照随机数字表法将其均分为BP组和对照组。BP组接受持续BP治疗；对照组接受常规治疗。结果：116例ARF患者病因：68.1%（79例）为肾前性；16.4%（19例）为肾性；6.9%（8例）为肾后性；其他8.6%（10例）。其首要疾病诱发因素为感染，占29.3%（34例）。BP组总有效率高达87.9%，对照组为51.7%，两组比较差异有统计学意义（P<0.01）。且BP组死亡率显著低于对照组，两组比较差异有统计学意义（P<0.05）。BP组BUN、Scr各项生化指标均明显低于对照组，两组比较差异有统计学意义（P<0.05）。BP组患者血Na+、血K+及血Ca2+等电解质水平均明显获得改善，且均显著优于对照组，两组比较差异均有统计学意义（P<0.05）。结论：ARF的主要病因是肾前性因素，主要诱发因素是感染。给予ARF患者持续BP治疗，可以提高治疗效果，降低患者死亡率，同时可以明显降低血BUN、Scr等指标，改善患者血电解质水平，有益于缓解ARF病情和严重程度，有助于ARF患者尽快恢复。
目的：探討持續血液淨化（BP）在腎內科治療中的療效。方法：選擇116例ARF患者，按照隨機數字錶法將其均分為BP組和對照組。BP組接受持續BP治療；對照組接受常規治療。結果：116例ARF患者病因：68.1%（79例）為腎前性；16.4%（19例）為腎性；6.9%（8例）為腎後性；其他8.6%（10例）。其首要疾病誘髮因素為感染，佔29.3%（34例）。BP組總有效率高達87.9%，對照組為51.7%，兩組比較差異有統計學意義（P<0.01）。且BP組死亡率顯著低于對照組，兩組比較差異有統計學意義（P<0.05）。BP組BUN、Scr各項生化指標均明顯低于對照組，兩組比較差異有統計學意義（P<0.05）。BP組患者血Na+、血K+及血Ca2+等電解質水平均明顯穫得改善，且均顯著優于對照組，兩組比較差異均有統計學意義（P<0.05）。結論：ARF的主要病因是腎前性因素，主要誘髮因素是感染。給予ARF患者持續BP治療，可以提高治療效果，降低患者死亡率，同時可以明顯降低血BUN、Scr等指標，改善患者血電解質水平，有益于緩解ARF病情和嚴重程度，有助于ARF患者儘快恢複。
목적：탐토지속혈액정화（BP）재신내과치료중적료효。방법：선택116례ARF환자，안조수궤수자표법장기균분위BP조화대조조。BP조접수지속BP치료；대조조접수상규치료。결과：116례ARF환자병인：68.1%（79례）위신전성；16.4%（19례）위신성；6.9%（8례）위신후성；기타8.6%（10례）。기수요질병유발인소위감염，점29.3%（34례）。BP조총유효솔고체87.9%，대조조위51.7%，량조비교차이유통계학의의（P<0.01）。차BP조사망솔현저저우대조조，량조비교차이유통계학의의（P<0.05）。BP조BUN、Scr각항생화지표균명현저우대조조，량조비교차이유통계학의의（P<0.05）。BP조환자혈Na+、혈K+급혈Ca2+등전해질수평균명현획득개선，차균현저우우대조조，량조비교차이균유통계학의의（P<0.05）。결론：ARF적주요병인시신전성인소，주요유발인소시감염。급여ARF환자지속BP치료，가이제고치료효과，강저환자사망솔，동시가이명현강저혈BUN、Scr등지표，개선환자혈전해질수평，유익우완해ARF병정화엄중정도，유조우ARF환자진쾌회복。
Objective:To explore the role of continuous blood purification in the renal medical treatment.Method:116 patients with ARF were selected and divided into BP group and control group. BP groups:58 patients were treated with continuous BP.Control group:58 patients were treated with conventional therapy.Result:The etiologies of 116 patients with ARF:116 cases(68.1%)were prerenal;19 cases(16.4%)were renal,8 cases (6.9%)were postrenal,others were 8.6%(10 cases). Its primary disease risk factors were infection,accounted for 29.3%(34 cases).Efficiency of BP group was as high as 87.9%,and was obviously higher than that of control group(P<0.01),and the mortality rate was significantly lower than control group(P<0.05). BUN,Scr and biochemical indicators of 58 patients in BP group were significantly lower than the control group(P<0.05). Blood Na+, K+and Ca2+blood,blood electrolyte levels of patients in BP group significantly improved,and were significantly better than the control group(P<0.05). Conclusion:The main etiologies of patients with ARF are prerenal,and the main inducing factor is infection. Continuous blood purification treating patients with ARF,can improve the effect of treatment,reduce mortality of patients,and also can significantly decrease the blood BUN,Scr and other indicators, improve the patients’ blood electrolyte level. It is conducive to ease the ARF illness and severity,and it can help ARF patients resume as soon as possible.
